retatrutide clinical trials phase drug retatrutide Retatrutide: What It Is & How This New Works eli lilly 3 trial – A Study of Retatrutide (LY3437943)

Semaglutide + B6 is a GLP-1 receptor agonist, meaning it mimics a hormone your body naturally produces (glucagon-like peptide-1) that helps regulate appetite, blood sugar, and how full you feel after eating

If youre considering compounded GLP-1s online, watch for red flags

As of March 2025, 11 states cover GLP-1s for weight loss under their state employee health plan, nine states provide coverage under their state Medicaid program, and five states provide coverage under both programs

Some patients prefer taking a pill every morning as part of their routine

However, the results regarding postprandial GLP-1 secretion and fasting GLP-1 between individuals with versus without T2DM are inconsistent